Qritive funding, investors and company details

Qritive is an emerging Healthcare startup from Pune, working in the space of Healthtech company that leverages artificial intelligence to transform pathology and improve cancer diagnosis.

Company: Qritive AI India Private Limited
Sector: Healthcare
Location: Pune
Total funding raised: ₹61.31 Cr

Company overview

Qritive is a healthtech company that leverages artificial intelligence to transform pathology and improve cancer diagnosis. It develops AI-powered diagnostic platforms that analyze microscopy images and patient data, enabling faster, more consistent, and cost-effective cancer detection. Qritive was established to address long-standing challenges in pathology such as slow turnaround times, inconsistent diagnoses, and workflow inefficiencies. Its solutions integrate AI and natural language processing to assist doctors in analyzing both medical images and patient histories, thereby enhancing diagnostic accuracy and efficiency. The company’s mission is to continuously innovate and provide reliable, easy-to-use clinical AI solutions that advance health equity and improve patient outcomes. Its technology is designed to seamlessly fit into everyday pathology workflows, ensuring adoption without disrupting existing practices.

Funding rounds

Latest round: $ 7.50 Mn (₹61.31 Cr.), 2023-01-11. Investors: MassMutual Ventures (MMV), Exfinity Venture Partners